Katelyn is a reporter with CNET covering artificial intelligence, including chatbots, image and video generators. Her work explores how new AI technology is infiltrating our lives, shaping the content ...

Quick question: how did you learn to code? It probably wasn’t bribing someone a year or two ahead of you in CS to finish all your homework, but that’s exactly what ‘vibe coders’ are doing — even in ...

The Tamilaga Vettri Kazhagam (TVK) Cabinet, led by Chief Minister C. Joseph Vijay, was expanded on Thursday (May 21, 2026), with the induction of 23 new members, including two Congress MLAs. The ...

Vijay, the newly sworn-in chief minister of Tamil Nadu, has had a stellar career as an actor and on-screen lead. But ‘Thalapathy', as he is commonly known, isn't the only one from his profession in ...

Tamil Nadu govt formation highlights: Updates to this blog have ended, follow here for latest news. Tamilaga Vettri Kazhagam (TVK) chief Vijay is set to take oath as Tamil Nadu chief minister today.

Tamil Nadu Government Formation Highlights: Actor-turned-politician Vijay had met Tamil Nadu Governor RV Arlekar and staked a claim to form the government. According to sources, the oath-taking is set ...

Amid the ongoing political tussle over government formation in Tamil Nadu, Tamilaga Vettri Kazhagam (TVK) chief Vijay has sought an appointment with Governor RN Ravi on Friday evening. At the same ...

Tamil Nadu Election Results 2026 Highlights: Actor-turned-politician Vijay, who made a blockbuster debut in politics by breaking the DMK's and AIADMK's traditional duopoly, met Tamil Nadu Governor ...

To secure a majority and form the government, Tamilaga Vettri Kazhagam is likely to seek backing from smaller parties such as the Congress, PMK, Left parties, CPM, and VCK, which together could help ...

Pictures of Vijay being sold outside a counting station in Tamil Nadu on Monday Film star-turned-politician C Joseph Vijay is on the cusp of history in Tamil Nadu state. On Monday, his political party ...

Feb 27 (Reuters) - Flagship-backed Generate Biomedicines' shares fell more than 6% in their Nasdaq debut on Friday, giving the drug developer a valuation of $1.91 billion, as lingering market ...